80 related articles for article (PubMed ID: 2257189)
1. [Esophageal motility disorders in cirrhotics treated by sclerosing the varices].
Uribarrena R; Jiménez J; Fortún MT; Jiménez C; Guerra A; Borda F
Rev Esp Enferm Dig; 1990 Jul; 78(1):1-5. PubMed ID: 2257189
[TBL] [Abstract][Full Text] [Related]
2. [Morphology and function of the esophagus after sclerotherapy of esophageal varices in cirrhotic patients].
Bretagne JF; Gosselin A; Le Jean-Colin I; Morisot D; Gastard J
Gastroenterol Clin Biol; 1987 Jan; 11(1):48-55. PubMed ID: 3556959
[TBL] [Abstract][Full Text] [Related]
3. Sequential esophageal motility studies after endoscopic injection sclerotherapy: a prospective investigation.
Grande L; Planas R; Lacima G; Boix J; Ros E; Esteve M; Morillas R; Gasull MA
Am J Gastroenterol; 1991 Jan; 86(1):36-40. PubMed ID: 1986552
[TBL] [Abstract][Full Text] [Related]
4. Esophageal motility abnormalities in cirrhotic patients before and after endoscopic variceal treatment.
Fass R; Landau O; Kovacs TO; Ippoliti AF
Am J Gastroenterol; 1997 Jun; 92(6):941-6. PubMed ID: 9177506
[TBL] [Abstract][Full Text] [Related]
5. [Manometric findings after sclerotherapy for esophageal varices].
Arcidiaco M; Perricelli D; Turpini F; Poggi L; Arcelloni S
Chir Ital; 1989; 41(4-6):213-22. PubMed ID: 2641732
[TBL] [Abstract][Full Text] [Related]
6. Treatment of esophageal varices: low versus high dose of 5% ethanolamine oleate.
Neeman A; Leiser A; Kadish U
Am J Gastroenterol; 1991 Sep; 86(9):1182-4. PubMed ID: 1882797
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis. A randomized controlled trial evaluating effect of sclerosant concentration.
Dowidar N; Hafez A
J Egypt Soc Parasitol; 2002 Aug; 32(2):537-49. PubMed ID: 12214931
[TBL] [Abstract][Full Text] [Related]
9. Gastroesophageal reflux in cirrhotic patients without esophageal varices.
Zhang J; Cui PL; Lv D; Yao SW; Xu YQ; Yang ZX
World J Gastroenterol; 2011 Apr; 17(13):1753-8. PubMed ID: 21483637
[TBL] [Abstract][Full Text] [Related]
10. Gastric bleeding after endoscopic injection sclerotherapy for esophageal varices may be fatal.
Higashi H; Kitano S; Hashizume M; Yamaga H; Wada H; Sugimachi K
Int Surg; 1991; 76(4):214-7. PubMed ID: 1778718
[TBL] [Abstract][Full Text] [Related]
11. Development of early squamous cell carcinoma of the esophagus after endoscopic injection sclerotherapy for esophageal varices.
Tanoue K; Hashizume M; Ohta M; Ueno K; Kitano S; Sugimachi K
Hepatogastroenterology; 1995; 42(6):792-6. PubMed ID: 8847025
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic sclerotherapy for esophageal varices in high-risk cirrhotic patients selected by endoscopic and hemodynamic criteria: a randomized, single-center controlled trial.
Paquet KJ; Kalk JF; Klein CP; Gad HA
Endoscopy; 1994 Nov; 26(9):734-40. PubMed ID: 7712967
[TBL] [Abstract][Full Text] [Related]
13. Early changes in esophageal motility after endoscopic variceal sclerotherapy or ligation.
Narawane NM; Bhatia SJ; Sheth MD; Dherai A; Abraham P; Paranjape AY; Mistry FP
Indian J Gastroenterol; 1999; 18(1):11-4. PubMed ID: 10063739
[TBL] [Abstract][Full Text] [Related]
14. Esophageal motility in cirrhotics with and without esophageal varices.
Passaretti S; Mazzotti G; de Franchis R; Cipolla M; Testoni PA; Tittobello A
Scand J Gastroenterol; 1989 Apr; 24(3):334-8. PubMed ID: 2734592
[TBL] [Abstract][Full Text] [Related]
15. Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices.
Krige JE; Kotze UK; Bornman PC; Shaw JM; Klipin M
Ann Surg; 2006 Nov; 244(5):764-70. PubMed ID: 17060770
[TBL] [Abstract][Full Text] [Related]
16. Esophageal function after sclerotherapy of bleeding varices.
Sauerbruch T; Wirsching R; Leisner B; Weinzierl M; Pfahler M; Paumgartner G
Scand J Gastroenterol; 1982 Sep; 17(6):745-51. PubMed ID: 6984219
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of 2 years' experience with elective endoscopic sclerotherapy of hemorrhagic esophageal varices in cirrhotic patients].
Bretagne JF; Morisot D; Gastard J
Gastroenterol Clin Biol; 1985 Nov; 9(11):809-13. PubMed ID: 3878811
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic sclerotherapy of oesophageal varices. A clinical study.
Söderlund C
Acta Chir Scand Suppl; 1985; 524():1-86. PubMed ID: 3893006
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic sclerotherapy of bleeding esophageal varices. A comparative study of results in patients with schistosomiasis and cirrhosis.
Sakai P; Boaventura S; Capacci ML; Macedo TM; Ishioka SZ
Endoscopy; 1988 Jul; 20(4):134-6. PubMed ID: 3263266
[TBL] [Abstract][Full Text] [Related]
20. [Prophylactic sclerosing of esophageal varices. Results of a prospective randomized 7-year longitudinal study].
Wördehoff D; Spech HJ
Dtsch Med Wochenschr; 1987 Jun; 112(24):947-51. PubMed ID: 3496202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
